Bay Area biotech’s $100M investment in Oregon is on track


The South San Francisco-based maker of synthetic DNA plans to be in operation in the Portland area by January.

Previous PPP loan forgiveness trudges ahead, pushed by 2021 activity
Next California biotech's $100M investment in Oregon is on track